MASSARI, SERENA
 Distribuzione geografica
Continente #
AS - Asia 5.026
NA - Nord America 3.942
EU - Europa 2.903
SA - Sud America 390
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 12.336
Nazione #
US - Stati Uniti d'America 3.843
CN - Cina 2.515
SG - Singapore 1.268
IT - Italia 705
VN - Vietnam 411
IE - Irlanda 399
RU - Federazione Russa 371
HK - Hong Kong 360
SE - Svezia 325
BR - Brasile 305
UA - Ucraina 216
DE - Germania 190
FR - Francia 146
FI - Finlandia 129
GB - Regno Unito 105
KR - Corea 88
BE - Belgio 73
IN - India 69
BD - Bangladesh 59
PL - Polonia 46
CA - Canada 44
AT - Austria 42
TR - Turchia 41
MX - Messico 40
RO - Romania 35
JP - Giappone 33
NL - Olanda 30
AR - Argentina 29
IQ - Iraq 27
SA - Arabia Saudita 27
PK - Pakistan 26
ES - Italia 23
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
ID - Indonesia 16
ZA - Sudafrica 14
CH - Svizzera 13
EC - Ecuador 13
CO - Colombia 12
CI - Costa d'Avorio 11
CL - Cile 9
ET - Etiopia 9
PH - Filippine 9
VE - Venezuela 9
EG - Egitto 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
LB - Libano 7
GR - Grecia 6
LV - Lettonia 6
JO - Giordania 5
PA - Panama 5
IR - Iran 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
AL - Albania 3
AO - Angola 3
CR - Costa Rica 3
DZ - Algeria 3
EU - Europa 3
HR - Croazia 3
IL - Israele 3
KG - Kirghizistan 3
PY - Paraguay 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
DK - Danimarca 2
GE - Georgia 2
HU - Ungheria 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
Totale 12.326
Città #
Guangzhou 2.081
Singapore 937
Chandler 572
Perugia 418
San Jose 414
Dublin 399
Hong Kong 348
Dong Ket 243
Ashburn 228
San Mateo 201
Boardman 152
Santa Clara 147
Jacksonville 110
Beijing 108
Moscow 97
Lauterbourg 90
Medford 89
Princeton 88
Seoul 85
Altamura 82
Los Angeles 82
Brussels 73
The Dalles 72
Ann Arbor 71
Ho Chi Minh City 62
Munich 61
Lawrence 60
Wilmington 60
New York 57
Fremont 44
São Paulo 43
Andover 41
West Jordan 38
Piscataway 37
Hanoi 34
Helsinki 33
Orem 33
Vienna 32
Redmond 31
Council Bluffs 30
Tokyo 29
Turku 29
Warsaw 28
Bucharest 26
Saint Petersburg 25
Dallas 23
Dearborn 23
Brooklyn 21
Buffalo 20
Norwalk 20
Montreal 19
Rome 19
Atlanta 18
Hefei 18
Ankara 17
Redwood City 17
Phoenix 16
Spoleto 16
Denver 15
Dhaka 15
Houston 15
Chennai 14
Chicago 14
Mexico City 14
Des Moines 13
Manchester 12
Nuremberg 12
Riyadh 12
Secaucus 12
Abidjan 11
Baghdad 11
Hanover 11
London 11
Poplar 11
Tashkent 11
Porto Alegre 10
Seattle 10
Woodbridge 10
Amsterdam 9
Columbus 9
Da Nang 9
Izmir 9
Jeddah 9
Shanghai 9
Stockholm 9
Addis Ababa 8
Charlotte 8
Johannesburg 8
Lappeenranta 8
Mumbai 8
Olomouc 8
Rio de Janeiro 8
Toronto 8
Barnet 7
Belo Horizonte 7
Changsha 7
Den Haag 7
Haiphong 7
Lahore 7
Querétaro 7
Totale 8.687
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.140
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 333
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 320
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 204
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 182
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 155
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 153
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 147
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 144
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 143
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 142
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 140
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 139
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 137
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 134
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 134
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 127
6-Desfluoroquinolones as promising HIV transcription inhibitors 126
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 126
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 123
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 122
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 117
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 117
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 116
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 116
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 115
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 113
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 113
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 112
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 112
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 112
A new quinolone derivative with ultra-potent anti-HIV activity. 111
A New Derivative with Ultra-Potent Anti-HIV Activity 110
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 110
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 110
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 110
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 109
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 107
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 105
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 104
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 103
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 103
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 102
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 101
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 100
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 100
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 100
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 99
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 97
6-Aminoquinolones targeting HCV NS5B polymerase. 97
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 95
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 93
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 92
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 91
New compounds targeting the rna polymerase of influenza a and b viruses. 90
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 89
Phospholipidosis effect of drugs by adsorption into lipid monolayers 89
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 89
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 89
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 88
In Vitro effects of alternative smoking devices on oral cells: Electronic cigarette and heated tobacco product versus tobacco smoke 87
The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication 86
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy 84
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 84
Biotinylated Tryptophan Catabolites for Target Fishing. 84
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 83
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 81
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly 80
Compounds for use in the treatment of cancer and inflammatory conditions 79
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 78
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 78
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 77
Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate-Early 2 Protein, a Promising Target for Anti-HCMV Treatment 75
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 75
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 74
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 74
Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity. 74
Disegno e sintesi di agenti anti-HIV a duplice attività 73
Small molecole targeting HPV E6 and E7 oncoproteins expression. 73
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 70
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 70
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 69
Q-raKtion: A Semiautomated KNIME Workflow for Bioactivity Data Points Curation 68
Nuovi 6-DFQ come inibitori della transattivazione dell’HIV-1. Abstr O15 67
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 67
SMALL MOLECULES TARGETING HPV E6 AND E7 ONCOPROTEINS EXPRESSION 67
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 65
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 65
Blocking HIV-1 Replication by Targeting the TAT-Hijacked Transcriptional Machinery 64
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 61
Ethyl 1,8-Naphthyridone-3-carboxylates Downregulate Human Papillomavirus-16 (HPV-16) E6 and E7 Oncogenes Expression 60
NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3‐c][1,2]benzothiazine 5,5‐Dioxide Derivatives 57
Studies on anti-HIV Quinolones 57
Protein-protein interactions by influenza polymerase subunits as drug targets 56
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 52
Totale 12.477
Categoria #
all - tutte 46.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 0 0 0 0 0 0 259
2021/2022940 31 144 18 66 73 7 24 242 69 35 111 120
2022/20231.588 96 281 19 161 155 151 3 102 514 15 57 34
2023/20242.830 39 116 37 24 14 22 2.246 16 57 57 78 124
2024/20251.852 19 150 65 139 186 108 246 121 305 113 254 146
2025/20263.790 239 245 173 476 506 345 647 216 446 293 154 50
Totale 12.691